- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Researchers report a case of porphyria cutanea tarda associated with hepatitis C
Memphis, TN: A recent case study published in the New England Journal of Medicine (NEJM) describes a rare case of porphyria cutaneous yards associated with Hepatitis C.
The case is reported by Dr. Tejesh S. Patel and Dr. Evgeniya Teterina Mohammed from the University of Tennessee Health Science Center, Memphis, Tennessee.
Porphyria cutanea tarda (PCT) is the most common type of porphyrias. Usually, the disease manifests with dermatological signs, including skin fragility and vesciculo-bullous eruption on the hand and face, which become evident after exposure to sunlight.
The case in question is of a 65-year-old man who was presented to the dermatology clinic with a 6-month history of worsening lesions on his hands and forearms as well as fingernail thickening.
His medical history included end-stage renal disease and untreated hepatitis C virus infection. Physical examination showed crusted erosions and atrophic scars on the dorsal hands and forearms as well as scattered tense vesicles on the fingers and forearms. Onychodystrophy and subungual hyperkeratosis were observed in the fingernails. A 24-hour urine sample showed an elevated level of uroporphyrins (558 μg [672 nmol]; normal range, 0 to 24 μg [0 to 28 nmol]).
A diagnosis of porphyria cutanea tarda was made. Porphyria cutanea tarda is due to acquired or inherited uroporphyrinogen decarboxylase deficiency. Risk factors for acquired disease include alcohol use, hepatitis C or human immunodeficiency virus infection, smoking, and certain medications.
Treatment for hepatitis C virus infection with sofosbuvir–velpatasvir was initiated, and the patient was advised to avoid exposure to the sun. At follow-up 4 months after presentation, the patient's skin lesions and fingernail changes had abated. He had only minimal residual blistering on his forearms.
Reference:
The case study titled, "Porphyria Cutanea Tarda Associated with Hepatitis C," is published in the New England Journal of Medicine.
DOI: https://www.nejm.org/doi/full/10.1056/NEJMicm2035140
DOI: 10.1056/NEJMicm2035140
Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email:Â editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751